Sichenzia Ross Ference Kesner LLP Represents China Internet Nationwide Financial Services Inc. on $20 Million Public Offering
Press Release – New York, NY – July 31, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented China Internet Nationwide Financial Services Inc. (NASDAQ: CIFS), a provider of financial advisory services to the underserved small-to-medium sized enterprises in China, in an initial public offering of 2,023,146 ordinary shares for a total of $20,231,460 at $10.00 per share. The shares are expected to begin trading on the NASDAQ Global Market on August 8, 2017 under the symbol “CIFS.”
The Sichenzia Ross Ference Kesner LLP team was led by partner Benjamin Tan and associate Will Rao.
.jpg)
Sichenzia Ross Ference LLP
Sichenzia Ross Ference LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals. We also represent clients in a range of residential and commercial real estate and trusts and estates matters.
Visit SRF's LinkedIn page
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Attorneys Selected for Inclusion on 2019 Super Lawyers Lists - October 16, 2019
- Sichenzia Ross Ference LLP to Join Client Relmada Therapeutics, Inc. at Nasdaq Opening Bell Ringing - October 15, 2019
- Sichenzia Ross Ference LLP Congratulates Relmada Therapeutics, Inc., on NASDAQ Uplisting - October 10, 2019
